PET imaging of mitochondrial complex i with 18F-BCPP-EF in the brains of MPTP-treated monkeys

Journal of Nuclear Medicine

Volumn 57, Issue 6, 2016, Pages 950-953

  Tsukada, Hideo ^a   Kanazawa, Masakatsu ^a   Ohba, Hiroyuki ^a   Nishiyama, Shingo ^a   Harada, Norihiro ^a   Kakiuchi, Takeharu ^a  

^a CENTRAL RESEARCH LABORATORY   (Japan)

Author keywords

Dopamine synthesis; Dopamine transporter; Mitochondria complex I; MPTP monkey

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 TERT BUTYL 4 CHROLO 5 (6 (2 (2 FLUORINE 18 FLUOROETHOXY)ETHOXY)PYRIDIN 3 YLMETHOXY) 2H PYRIDAZIN 3 ONE; 6 CARBON 11 METHYL M TYROSINE; 6 FLUORODOPAMINE F 18; CARBON 11 3,4 DIHYDROXY PHENYL ALANINE (BETA CARBON 11 LEVODOPA); DOPAMINE TRANSPORTER; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; 2-TERT-BUTYL-4-CHLORO-5-(6-(2-(2-FLUOROETHOXY)ETHOXY)PYRIDIN-3-YLMETHOXY)-2H-PYRIDAZIN-3-ONE; PYRIDAZINE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; ENZYME ACTIVITY; HEMISPHERE; MACACA FASCICULARIS; MALE; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ANIMAL; BRAIN; DIAGNOSTIC IMAGING; DRUG EFFECTS; METABOLISM; PROCEDURES;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; ELECTRON TRANSPORT COMPLEX I; MACACA FASCICULARIS; MALE; POSITRON-EMISSION TOMOGRAPHY; PYRIDAZINES; PYRIDINES;

EID: 84973594879     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.169615     Document Type: Article

References (23)

1. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: pathophysiologic and clinical implications. N Engl J Med. 1988;318:876-880.
2. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondria1 complex I deficiency in Parkinson's disease. J Neurochem. 1990;54: 823-827.
3. Keeney PM, Xie J, Capaldi RA, Bennett JP Jr. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci. 2006;26:5256-5264.
4. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacts of the substantia nigra by MPTP. Proc Natl Acad Sci USA. 1983;80:4546-4550.
5. Brooks DJ. Imaging approaches to Parkinson disease. J Nucl Med. 2010;51:596-609.
6. Tsukada H, Nishiyama S, Fukumoto D, Kanazawa M, Harada N. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study by comparison with 18F-BMS-747158-02 in rat brain. J Nucl Med. 2014; 55:473-480.
7. Tsukada H, Ohba H, Nishiyama S, Kanazawa M, Kakiuchi T, Harada N. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain. J Cereb Blood Flow Metab. 2014;34:708-714.
8. Tsukada H, Nishiyama S, Ohba H, KanazawaM, Kakiuchi T, Harada N. Comparing amyloid-b deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys. Eur J Nucl Med Mol Imaging. 2014;41:2127-2136.
9. Muramatsu S, Okuno T, Suzuki Y, et al. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. Synapse. 2009;63:541-548.
10. Kanazawa M, Ohba H, Harada N, Kakiuchi T, Muramatsu S, Tsukada H. Evaluation of 6-11C-methyl-m-tyrosine as a PET probe for presynaptic dopaminergic activity: a comparison PET study with β-11C-L-DOPA and 18F-FDOPA in Parkinson's disease monkeys. J Nucl Med. November 12, 2015 [Epub ahead of print].
11. Dannals RF, Neumeyer JL, Milius RA, Ravert HT, Wilson AA, Wagner HN. Synthesis of a radiotracer for studying dopamine uptake site in vivo using PET: (2β-carbomethoxy-3β- (p-fluorophenyl)-[N-11C-methyl]tropane) ([11C]CFT or [11C]WIN 35,428). J Labelled Comp Radiopharm. 1993;33:147-152.
12. Bjurling P, Watanabe Y, Oka S, Nagasawa T, Yamada H, Långström B. Multienzymatic synthesis of β-11C-labelled L-tyrosine and L-DOPA. Acta Chem Scand. 1990;44:183-188.
13. Lemaire C, Gillet S, Guillouet S, Plenevaux A, Aerts J, Luxen A. Highly enantioselective synthesis of no-carrier-added 6-[18F]fluoro-L-dopa by chiral phasetransfer alkylation. Eur J Org Chem. 2004;2004:2899-2904.
14. Kanazawa M, Ohba H, Iwazaki A, Kakiuchi T, Tsukada H. Synthesis of 6-11Cmethyl- m-tyrosine (11C-6MemTyr) for dopamine synthesis imaging in living brain using PET. Bioorg Med Chem. 2015;23:729-734.
15. Watanabe M, Okada H, Shimizu K, et al. A high resolution animal PET scanner using compact PS-PMT detectors. IEEE Trans Nucl Sci. 1997;44:1277-1282.
16. Jones EG, Stone JM, Karten HJ. High-resolution digital brain atlases: a Hubble telescope for the brain. Ann N Y Acad Sci. 2011;1225(suppl 1):E147-E159.
17. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539.
18. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab. 1985;5:584-590.
19. Gjedde A, Reith J, Dyve S, et al. Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci USA. 1991;88:2721-2725.
20. Yalamanchili P, Wexler E, Hayes M, et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol. 2007;14:782-788.
21. Madar I, Ravert H, Nelkin B, et al. Characterization of membrane potentialdependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation. Eur J Nucl Med Mol Imaging. 2007;34:2057-2065.
22. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5:235-245.
23. Scatton B, Javoy-Agid F, Rouquier L, Dubois B, Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 1983;275:321-328.